Corticosteroid Treatments in Males With Duchenne Muscular Dystrophy

Corticosteroids in Duchenne muscular dystrophy: Major variations in practice

(2013) Robert C. Griggs et al.   MUSCLE & NERVE

LTBP4genotype predicts age of ambulatory loss in duchenne muscular dystrophy

(2012) Kevin M. Flanigan et al.   ANNALS OF NEUROLOGY

Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy

(2012) V. Ricotti et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Early corticosteroid treatment in 4 duchenne muscular dystrophy patients: 14-year follow-up

(2012) Luciano Merlini et al.   MUSCLE & NERVE

Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): Case Definition in Surveillance for Childhood-Onset Duchenne/Becker Muscular Dystrophy

(2010) Katherine D. Mathews et al.   JOURNAL OF CHILD NEUROLOGY

Change in Natural History of Duchenne Muscular Dystrophy With Long-term Corticosteroid Treatment: Implications for Management

(2010) Richard T. Moxley et al.   JOURNAL OF CHILD NEUROLOGY

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy

(2010) E. Pegoraro et al.   NEUROLOGY

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

(2009) Katharine Bushby et al.   LANCET NEUROLOGY

Deflazacort Use in Duchenne Muscular Dystrophy: An 8-Year Follow-Up

(2008) Sylvie Houde et al.   PEDIATRIC NEUROLOGY